Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07498504 · ClinicalTrials.gov registry record
Understanding the Long-term Impact of COVID-19 in Adults
A clinical trial, sponsored by NYU Langone Health.
- Not yet
- Registry status
- 5,205
- Enrollment target
NCT07498504 is a clinical trial that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 5,205 participants.
The verdict
NCT07498504 has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- 5,205 participants
- Enrollment target
Study Summary
Long COVID (LC) affects an estimated 5-10% of individuals with SARS-CoV-2 causing a persistent physical, cognitive, and functional impairment with potentially severe socioeconomic consequences. While RECOVER-Adult cycle 1 established the largest, most comprehensive U.S. adult LC cohort (14,730 participants), key questions remain about long-term disease trajectories, biological mechanisms, and late-emerging complications. RECOVER-Adult cycle 2 will follow selected participants for two years each, focusing on neurocognitive, cardiopulmonary and infection-associated chronic conditions (IACC) such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and autonomic dysfunction. Using a case-cohort design, the study will investigate disease persistence versus resolution, biological mechanisms, and onset of new chronic illnesses, generating critical insights to guide prevention, treatment, and public health policy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,205 participants |
| Start Date | 2026-05 |
| Est. Completion | 2030-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07498504
The ClinicalTrials.gov registry entry for NCT07498504 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 5,205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07498504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07498504 about?
NCT07498504 is a clinical study titled "Understanding the Long-term Impact of COVID-19 in Adults". Long COVID (LC) affects an estimated 5-10% of individuals with SARS-CoV-2 causing a persistent physical, cognitive, and functional impairment with potentially severe socioeconomic consequences. While RECOVER-Adult cycle 1 established the largest, most comprehensive U.S. adult LC cohort (14,730 parti...
What is the current status of trial NCT07498504?
This trial is currently not yet recruiting. The enrollment target is 5,205 participants. The study started on 2026-05. Estimated completion is 2030-04.
Who is sponsoring clinical trial NCT07498504?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.